Dr. Lugogo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
380 Parkland Plaza
Ann Arbor, MI 48103Phone+1 734-998-7380
Clinical Expertise
- Refractory asthma
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2001 - 2004
Virginia Commonwealth University School of MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2017 - 2027
NC State Medical License 2001 - 2018- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellows Teaching Award Pulmonary Division, University of Michigan, 2019
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
- PackHealth: Asthma Engagement Tool Start of enrollment: 2015 Aug 01
- Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- 412 citationsProthrombotic autoantibodies in serum from patients hospitalized with COVID-19.Yu Zuo, Shanea K. Estes, Ramadan A. Ali, Alex A. Gandhi, Srilakshmi Yalavarthi
Science Translational Medicine. 2020-11-18 - 620 citationsOral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.Parameswaran Nair, Sally E. Wenzel, Klaus F. Rabe, Arnaud Bourdin, Njira L Lugogo
The New England Journal of Medicine. 2017-05-22 - 14 citationsConsensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on de...Michael Blaiss, John Oppenheimer, Mark Corbett, Leonard Bacharier, Jonathan Bernstein
Annals of Allergy, Asthma & Immunology. 2023-12-01
Press Mentions
NAVIGATOR Steers Uncontrolled Asthma Toward Calmer SeasMay 18th, 2022- NAVIGATOR: Nearly Half of Patients with Severe, Uncontrolled Asthma Improved with TezepelumabMay 17th, 2022
- When All Else Failed, Biologics Helped Her Breathe AgainFebruary 28th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
